GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (LTS:0DPB) » Definitions » Deferred Tax

Bavarian Nordic AS (LTS:0DPB) Deferred Tax : kr-17 Mil (TTM As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Bavarian Nordic AS Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Bavarian Nordic AS's change in deferred tax for the three months ended in Dec. 2024 was kr-24 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was kr-17 Mil.

Bavarian Nordic AS Deferred Tax Historical Data

The historical data trend for Bavarian Nordic AS's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Deferred Tax Chart

Bavarian Nordic AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 10.35 15.77 7.75 -16.62

Bavarian Nordic AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.07 0.31 4.86 1.97 -23.76

Bavarian Nordic AS Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-17 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Deferred Tax Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (LTS:0DPB) » Definitions » Deferred Tax
Comparable Companies
OCSE:GUBRA OCSE:PEG OCSE:ALK B OCSE:ZEAL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170
Traded in Other Exchanges
BVNRY:USA BVNKF:USA BAVA:Denmark BV3:Germany BAVA:Austria
Address
Philip Heymans Alle 3, Hellerup, DNK, 2900
Website
https://www.bavarian-nordic.com
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines